Member news

First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the Neoadjuvant Setting in Melanoma

More at 4sc.com…

ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule

More at b3cnewswire.com…

BRAIN AG publishes annual report for financial year 2018/19

More at brain-biotech.com…

BioMed X starts new schizophrenia research program with Boehringer Ingelheim

More at bio.mx…

apceth Starts Commercial Manufacturing of Zynteglo™ ▼, bluebird bio’s Gene Therapy for Transfusion-Dependent β-Thalassemia

More at b3cnewswire.com…

MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab

More at morphosys.com…